Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Analysis of CN118164991A reveals a palladium-free route for aminopyrimidopyrazole derivatives, offering cost reduction in API intermediate manufacturing and high purity.
Advanced four-step synthesis of Pritelivir using cost-effective raw materials ensures high purity and scalable production for global supply chains.
Novel Grignard-based route for Saxagliptin intermediate A1 offering high purity and industrial scalability for API manufacturing.
Novel patent CN106008316A offers cost-effective Ledipasvir intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Advanced hydrolysis method for high-purity ganciclovir-CBZ-L-mono-valine ester. Eliminates chromatography for cost-effective API intermediate manufacturing.
Patent CN119080882A reveals a green TAPS method for eptifibatide derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111253271A reveals a safer micro-reactor route for methyl 2-amino-3-nitrobenzoate, offering significant yield improvements and cost reduction in API manufacturing.
Advanced patent method for tilmicosin phosphate ensures high purity and scalable veterinary drug production with optimized solvent safety and cost efficiency.
Patent CN101928254A details novel benzotriazole esters and amides with potent anti-tumor activity, offering streamlined EDC-catalyzed routes for cost-effective API manufacturing.
Novel synthesis method for high-yield pyridinium macrocycles. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN106083623B reveals a safer microchannel route for 5-aminosalicylic acid. Achieve high purity and yield with reduced environmental impact for reliable supply.
Novel patent CN109575019A details high-yield synthesis of 5-bromo-7-azaindole. Offers cost reduction and supply chain reliability for API manufacturing.
Patent CN101801382B reveals a scalable route for DAPD using alpha-cyano additives, offering high stereoselectivity and cost-effective API manufacturing solutions.
Patent CN112661753A details a low-cost, high-yield route for 6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one suitable for industrial scale-up.
Patent CN115745778A reveals a novel seed-induced crystallization method for Bempedoic Acid, replacing inefficient column chromatography with high-purity scalable production.
Novel patent CN119954798A offers high purity Berberine Hydrochloride synthesis. Reduces heavy metal risks and improves supply chain reliability for pharmaceutical intermediates.
Advanced purification protocol for dehydroandrographolide succinate ensuring high purity and yield. Optimized for pharmaceutical intermediate supply chain efficiency and cost reduction.
Advanced synthesis of 3,3-disubstituted indolinones via copper-catalyzed radical cyclization. Cost-effective pharmaceutical intermediate manufacturing with scalable protocols.
Patent CN117466695A reveals low-cost cobalt catalysis for alkyne synthesis offering supply chain stability and reduced toxicity for pharmaceutical intermediates manufacturing.